merck glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Receptor Agonist Market Size,

This analysis examines publicly available formularies of plans available on the federally facilitated Affordable Care Act (ACA) Marketplace in 2024 to identify how utilization management tools are used for GLP-1 agonists

Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men

Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo , Wegovy (injection or tablet), or Zepbound (KwikPen ) weight loss medications for a $50 copayment for each 30-day supply

As use of these drugs is expected to expand to other health conditions, there is a pressing need for physical therapists to adapt their practices to support the long-term health goals of their patients and ensure optimal patient outcomes